Home
>
National Drug Code (NDC)
>
Prandin
Prandin - 35356-303-01 - (Repaglinide)
Drug Information of Prandin
| Product NDC: | 35356-303 |
| Proprietary Name: | Prandin |
| Non Proprietary Name: | Repaglinide |
| Active Ingredient(s): | .5 mg/1 & nbsp; Repaglinide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Prandin
| Product NDC: | 35356-303 |
| Labeler Name: | Lake Erie Medical DBA Quality Care Products LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020741 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101012 |
Package Information of Prandin
| Package NDC: | 35356-303-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (35356-303-01) |
NDC Information of Prandin
| NDC Code | 35356-303-01 |
| Proprietary Name | Prandin |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (35356-303-01) |
| Product NDC | 35356-303 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Repaglinide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101012 |
| Marketing Category Name | NDA |
| Labeler Name | Lake Erie Medical DBA Quality Care Products LLC |
| Substance Name | REPAGLINIDE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |
